Extended-spectrum β-lactamase-producing E. coli from retail meat and workers: genetic diversity, virulotyping, pathotyping and the antimicrobial effect of silver nanoparticles.
Antimicrobial resistance
E. coli
ESBL
Multidrug resistant
Retail meat
Silver nanoparticles
Journal
BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981
Informations de publication
Date de publication:
07 08 2023
07 08 2023
Historique:
received:
23
04
2023
accepted:
18
07
2023
medline:
9
8
2023
pubmed:
8
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
The spread of extended-spectrum β-lactamases (ESBL) producing E. coli from food animals and the environment to humans has become a significant public health concern. The objectives of this study were to determine the occurrence, pathotypes, virulotypes, genotypes, and antimicrobial resistance patterns of ESBL-producing E. coli in retail meat samples and workers in retail meat shops in Egypt and to evaluate the bactericidal efficacy of silver nanoparticles (AgNPs-H A total of 250 retail meat samples and 100 human worker samples (hand swabs and stool) were examined for the presence of ESBL- producing E. coli. Duck meat and workers' hand swabs were the highest proportion of ESBL- producing E. coli isolates (81.1%), followed by camel meat (61.5%). Pathotyping revealed that the isolates belonged to groups A and B1. Virulotyping showed that the most prevalent virulence gene was Shiga toxin 2 (stx2) associated gene (36.9%), while none of the isolates harbored stx1 gene. Genotyping of the identified isolates from human and meat sources by REP-PCR showed 100% similarity within the same cluster between human and meat isolates. All isolates were classified as MDR with an average multiple antibiotic resistance (MAR) index of 0.7. AgNPs-H Virulent MDR ESBL-producing E. coli were identified in retail meat products in Egypt, posing significant public health threats. Regular monitoring of ESBL-producing E. coli frequency and antimicrobial resistance profile in retail meat products is crucial to enhance their safety. AgNPs-H
Sections du résumé
BACKGROUND
The spread of extended-spectrum β-lactamases (ESBL) producing E. coli from food animals and the environment to humans has become a significant public health concern. The objectives of this study were to determine the occurrence, pathotypes, virulotypes, genotypes, and antimicrobial resistance patterns of ESBL-producing E. coli in retail meat samples and workers in retail meat shops in Egypt and to evaluate the bactericidal efficacy of silver nanoparticles (AgNPs-H
RESULTS
A total of 250 retail meat samples and 100 human worker samples (hand swabs and stool) were examined for the presence of ESBL- producing E. coli. Duck meat and workers' hand swabs were the highest proportion of ESBL- producing E. coli isolates (81.1%), followed by camel meat (61.5%). Pathotyping revealed that the isolates belonged to groups A and B1. Virulotyping showed that the most prevalent virulence gene was Shiga toxin 2 (stx2) associated gene (36.9%), while none of the isolates harbored stx1 gene. Genotyping of the identified isolates from human and meat sources by REP-PCR showed 100% similarity within the same cluster between human and meat isolates. All isolates were classified as MDR with an average multiple antibiotic resistance (MAR) index of 0.7. AgNPs-H
CONCLUSIONS
Virulent MDR ESBL-producing E. coli were identified in retail meat products in Egypt, posing significant public health threats. Regular monitoring of ESBL-producing E. coli frequency and antimicrobial resistance profile in retail meat products is crucial to enhance their safety. AgNPs-H
Identifiants
pubmed: 37550643
doi: 10.1186/s12866-023-02948-0
pii: 10.1186/s12866-023-02948-0
pmc: PMC10405496
doi:
Substances chimiques
Silver
3M4G523W1G
beta-Lactamases
EC 3.5.2.6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
212Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
FEMS Microbiol Lett. 2007 Dec;277(1):98-106
pubmed: 17986090
Microbiol Immunol. 2015 Mar;59(3):114-22
pubmed: 25644201
J Microbiol Methods. 2011 Oct;87(1):64-9
pubmed: 21791228
Sci Rep. 2020 Dec 15;10(1):21999
pubmed: 33319793
J Antimicrob Chemother. 2004 Feb;53(2):208-16
pubmed: 14729766
Int J Antimicrob Agents. 2016 Dec;48(6):598-606
pubmed: 27836380
FEMS Microbiol Lett. 2008 Feb;279(1):71-6
pubmed: 18081843
Int J Food Microbiol. 2020 Apr 2;318:108478
pubmed: 31855787
Appl Environ Microbiol. 2000 Mar;66(3):1205-8
pubmed: 10698793
Infect Drug Resist. 2018 Sep 26;11:1597-1603
pubmed: 30310295
J Antimicrob Chemother. 2007 Nov;60(5):1137-41
pubmed: 17855726
J Antimicrob Chemother. 2010 Sep;65(9):2037-40
pubmed: 20587611
Med Clin North Am. 1995 Jul;79(4):705-19
pubmed: 7791418
Vet Microbiol. 2016 Apr 15;186:37-43
pubmed: 27016755
PLoS One. 2011;6(6):e20819
pubmed: 21687635
Clin Microbiol Infect. 2012 Jul;18(7):646-55
pubmed: 22519858
Microb Drug Resist. 2021 Mar;27(3):424-432
pubmed: 32721263
Anaerobe. 2011 Dec;17(6):280-5
pubmed: 21497662
mBio. 2019 May 7;10(3):
pubmed: 31064835
FEMS Microbiol Lett. 2003 Jun 27;223(2):147-51
pubmed: 12829279
PLoS Genet. 2014 Dec 18;10(12):e1004776
pubmed: 25522320
Int J Med Microbiol. 2014 Jul;304(5-6):678-84
pubmed: 24856867
J Microbiol Methods. 2014 Jun;101:24-7
pubmed: 24685601
Molecules. 2015 May 18;20(5):8856-74
pubmed: 25993417
Infect Genet Evol. 2018 Nov;65:251-256
pubmed: 30071311
BMC Infect Dis. 2019 Oct 28;19(1):897
pubmed: 31660887
Drugs. 2019 Sep;79(14):1529-1541
pubmed: 31407238
Nat Rev Microbiol. 2010 Apr;8(4):251-9
pubmed: 20190823
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:144-53
pubmed: 18154538
Nat Rev Microbiol. 2010 Feb;8(2):105-16
pubmed: 20023663
PLoS One. 2015 Dec 30;10(12):e0144802
pubmed: 26716443
J Antimicrob Chemother. 2018 Feb 1;73(2):339-347
pubmed: 29165596
Ann Lab Med. 2012 Jul;32(4):270-5
pubmed: 22779068
J Clin Microbiol. 1990 Sep;28(9):1903-5
pubmed: 2229371
Environ Microbiol. 2008 Oct;10(10):2484-96
pubmed: 18518895
J Food Prot. 1996 Oct;59(10):1112-1122
pubmed: 31195470
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Appl Environ Microbiol. 1983 Jul;46(1):165-70
pubmed: 6351743
Lett Appl Microbiol. 2006 Sep;43(3):293-5
pubmed: 16910934
Curr Pharm Des. 2013;19(2):164-208
pubmed: 22894615
J Antimicrob Chemother. 2012 Sep;67(9):2090-100
pubmed: 22678728
Int J Food Microbiol. 2019 May 2;296:37-42
pubmed: 30844701
Clin Microbiol Rev. 2005 Oct;18(4):657-86
pubmed: 16223952
J Antimicrob Chemother. 2021 Feb 11;76(3):601-605
pubmed: 33331642
Clin Microbiol Rev. 2017 Apr;30(2):557-596
pubmed: 28275006
Infect Drug Resist. 2020 Oct 08;13:3485-3499
pubmed: 33116668
Emerg Infect Dis. 2003 May;9(5):585-91
pubmed: 12737743
Euro Surveill. 2013 Jan 24;18(4):20380
pubmed: 23369389
Antimicrob Agents Chemother. 2004 Aug;48(8):3179-81
pubmed: 15273145
Front Cell Infect Microbiol. 2013 Jan 18;2:171
pubmed: 23346554
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6433-4
pubmed: 27503658
Emerg Infect Dis. 2011 Jul;17(7):1216-22
pubmed: 21762575
Poult Sci. 2019 Jun 1;98(6):2622-2631
pubmed: 30690545
Euro Surveill. 2018 Feb;23(6):
pubmed: 29439754
Infect Drug Resist. 2018 Aug 15;11:1183-1187
pubmed: 30147346
Euro Surveill. 2016;21(6):
pubmed: 26898350
EFSA J. 2020 Mar 03;18(3):e06007
pubmed: 32874244
FEMS Immunol Med Microbiol. 1995 Oct;12(2):85-90
pubmed: 8589667
PLoS One. 2017 Sep 21;12(9):e0185326
pubmed: 28934348
J Vet Sci. 2012 Jun;13(2):145-52
pubmed: 22705736
Appl Biochem Biotechnol. 2017 Dec;183(4):1351-1361
pubmed: 28573605
Res Vet Sci. 2009 Apr;86(2):206-10
pubmed: 18783807
Clin Infect Dis. 2013 Feb;56(4):478-87
pubmed: 23243181
Gut Pathog. 2017 Oct 18;9:57
pubmed: 29075329
J Microbiol Methods. 2021 Oct;189:106314
pubmed: 34461553
PLoS One. 2019 Nov 8;14(11):e0224904
pubmed: 31703098
Expert Opin Drug Deliv. 2019 Apr;16(4):415-439
pubmed: 30897978
Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):726-30
pubmed: 14614596
Antimicrob Agents Chemother. 2000 Feb;44(2):421-4
pubmed: 10639375
Foodborne Pathog Dis. 2014 Feb;11(2):104-10
pubmed: 24093132
Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):69-75
pubmed: 28918585
Infect Immun. 1996 Apr;64(4):1441-5
pubmed: 8606115
Microb Pathog. 2020 Jun;143:104164
pubmed: 32198092
J Clin Microbiol. 2002 Oct;40(10):3613-9
pubmed: 12354854
Antibiotics (Basel). 2022 Dec 10;11(12):
pubmed: 36551452
Front Microbiol. 2019 Jan 15;9:3358
pubmed: 30697208
J Antimicrob Chemother. 2013 Feb;68(2):317-21
pubmed: 23034714
Rev Sci Tech. 2012 Apr;31(1):249-60
pubmed: 22849280
Int J Food Microbiol. 2017 Jan 16;241:283-290
pubmed: 27821357
J Antimicrob Chemother. 1991 Jun;27(6):863-4
pubmed: 1938695
Emerg Infect Dis. 2016 Apr;22(4):634-40
pubmed: 26982890
Infect Dis (Lond). 2016;48(1):18-25
pubmed: 26135711
PLoS One. 2015 Aug 18;10(8):e0136052
pubmed: 26284654
Ann Acad Med Singap. 2016 Dec;45(12):557-559
pubmed: 28062884